Zapanta, Ana .
HRN: 25-24-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2024
AMPICILLIN 1GM (VIAL)
06/23/2024
06/29/2024
IVT
2gm
Q6
Prom
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes